LuMind IDSC Foundation
Research & Resources for the Down syndrome community
Learn how to support this organization
LuMind IDSC Foundation
EIN: 37-1483975
as of November 2025
as of November 14, 2025
Programs and results
What we aim to solve
We’re focused on exciting research targeting the root cause with the objective of improving health and independence for our loved ones throughout their lifetimes. Our four priorities are: Preventing Alzheimer’s Disease, Increase Independence (including Cognition, Sleep, Behavior, Speech, and Regression), Develop Gene Therapies and Speed up Access to Treatments
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Research: DS-CTN Down syndrome clinical trials network
The Down Syndrome Clinical Trials Network was built to conduct large-scale, multi-site trials with experienced clinicians who are experts at providing medical care for individuals with Down syndrome. Founded in 2019, today the DS-CTN is accelerating research into the unmet medical needs of people with Down syndrome. 14 DS-CTN Sites in 10 States
Research: LIFE-DSR
The Longitudinal Investigation for the Enhancement of Down Syndrome Research (LIFE-DSR) is a multi-year, coordinated research study by medical and academic professionals to track and analyze the medical and physical data of 270 adults with Down syndrome. LIFE-DSR is an observational study. Teams in hospitals and universities collect data points (for example, height and weight, sleeping patterns, and blood samples) gathered over time to help researchers form a clearer picture of the physiology of people with DS
Research Consortium
Our Consortium bridges industry and Down syndrome experts to build a structured and focused translational approach to Down syndrome-related research. We create and drive high-impact research projects that identify and develop pre-clinical tools and clinical outcome measures to accelerate the pace of research efforts in the DS community.
Community Program: myDSC
myDSC is a free, online library designed specifically for the Down syndrome community. Curated by trusted professionals, myDSC is a comprehensive directory of evidence-based resources and useful tools for individuals with Down syndrome and their families. The library provides members with reliable, up-to-date information regarding: health and wellness, lifestyle, education, medical and research information.
Community Program: Annual Family Weekend
LuMind IDSC Family Weekend is the largest event of its kind for individuals with Down syndrome and their families. The event gathers more than 4,000 people at Great Wolf Lodge locations all across the country and Canada.
Community Program: LuMind IDSC Webinar Series
LuMind IDSC frequently hosts free webinars to keep the Down syndrome community and the research community up-to-date on the latest in Down syndrome research, Down syndrome resources, medical conditions and treatments, caregiver concerns, and mental health.
Community Program: Facebook Support Groups
We help connect people with other individuals with Down syndrome and their families by joining our Facebook groups. Facebook groups include: Adoptive Families Support, Babies and Toddlers, Conexion en Espanol, Grandparents, Prenatal Diagnosis and many others.
Where we work
-
Canada
-
United States
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
LuMind IDSC envisions a world where every person with Down syndrome thrives with improved health, independence, and opportunities to reach their fullest potential. We accelerate research to increase the availability of therapeutic, diagnostic, and medical care options and we empower families through education, connections, and support.
What are the organization's key strategies for making this happen?
Down syndrome research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective drugs and interventions to improve health and independence. We empower families through education, connections and support. Your gift is crucial to furthering these breakthroughs
What are the organization's capabilities for doing this?
What have they accomplished so far and what's next?
How we listen
Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.
-
How is your organization using feedback from the people you serve?
To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To make fundamental changes to our programs and/or operations, To inform the development of new programs/projects, To identify where we are less inclusive or equitable across demographic groups, To strengthen relationships with the people we serve, To understand people's needs and how we can help them achieve their goals
-
Which of the following feedback practices does your organization routinely carry out?
We collect feedback from the people we serve at least annually, We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We act on the feedback we receive, We share the feedback we received with the people we serve
-
What challenges does the organization face when collecting feedback?
It is difficult to get the people we serve to respond to requests for feedback
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2024 info
3.33
Months of cash in 2024 info
1.8
Fringe rate in 2024 info
18%
Funding sources info
Assets & liabilities info
Financial data
LuMind IDSC Foundation
Balance sheetFiscal Year: Oct 01 - Sep 30
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Fiscal Year: Oct 01 - Sep 30
This snapshot of LuMind IDSC Foundation’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
| Profitability info | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Unrestricted surplus (deficit) before depreciation | -$25,536 | $780,405 | -$1,189,068 | $470,009 | $875,922 |
| As % of expenses | -1.0% | 23.6% | -25.5% | 12.3% | 22.9% |
| Unrestricted surplus (deficit) after depreciation | -$35,962 | $714,823 | -$1,256,396 | $307,692 | $702,424 |
| As % of expenses | -1.4% | 21.2% | -26.6% | 7.7% | 17.6% |
| Revenue composition info | |||||
|---|---|---|---|---|---|
| Total revenue (unrestricted & restricted) | $1,863,831 | $5,267,215 | $2,742,364 | $3,159,544 | $4,039,327 |
| Total revenue, % change over prior year | -51.4% | 182.6% | -47.9% | 15.2% | 27.8% |
| Program services revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Investment income | 0.0% | 0.0% | 0.1% | 0.5% | 0.3% |
| Government grants | 0.0% | 6.2% | 0.0% | 11.0% | 0.0% |
| All other grants and contributions | 98.5% | 93.8% | 99.9% | 88.5% | 99.3% |
| Other revenue | 1.5% | 0.0% | 0.0% | 0.0% | 0.4% |
| Expense composition info | |||||
|---|---|---|---|---|---|
| Total expenses before depreciation | $2,560,366 | $3,302,344 | $4,659,529 | $3,817,206 | $3,818,208 |
| Total expenses, % change over prior year | -26.5% | 29.0% | 41.1% | -18.1% | 0.0% |
| Personnel | 37.3% | 38.7% | 46.4% | 44.8% | 52.3% |
| Professional fees | 11.8% | 6.2% | 6.9% | 13.3% | 6.6% |
| Occupancy | 2.1% | 1.4% | 1.2% | 1.5% | 0.4% |
| Interest | 0.5% | 0.0% | 0.1% | 0.0% | 0.0% |
| Pass-through | 39.9% | 45.6% | 9.6% | 0.0% | 0.0% |
| All other expenses | 8.4% | 8.0% | 35.8% | 40.4% | 40.7% |
| Full cost components (estimated) info | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total expenses (after depreciation) | $2,570,792 | $3,367,926 | $4,726,857 | $3,979,523 | $3,991,706 |
| One month of savings | $213,364 | $275,195 | $388,294 | $318,101 | $318,184 |
| Debt principal payment | $0 | $0 | $0 | $0 | $0 |
| Fixed asset additions | $230,923 | $0 | $272,265 | $0 | $0 |
| Total full costs (estimated) | $3,015,079 | $3,643,121 | $5,387,416 | $4,297,624 | $4,309,890 |
Capital structure indicators
| Liquidity info | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Months of cash | 1.3 | 5.6 | 2.4 | 2.2 | 1.8 |
| Months of cash and investments | 1.3 | 5.6 | 2.4 | 2.2 | 1.8 |
| Months of estimated liquid unrestricted net assets | -0.6 | 2.2 | -2.2 | -1.4 | 1.3 |
| Balance sheet composition info | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Cash | $283,239 | $1,551,887 | $943,623 | $707,582 | $580,373 |
| Investments | $0 | $0 | $0 | $0 | $0 |
| Receivables | $1,826,302 | $2,655,533 | $754,462 | $139,169 | $74,385 |
| Gross land, buildings, equipment (LBE) | $259,962 | $304,726 | $576,991 | $648,483 | $648,483 |
| Accumulated depreciation (as a % of LBE) | 8.9% | 29.1% | 27.0% | 49.1% | 75.8% |
| Liabilities (as a % of assets) | 65.8% | 38.9% | 33.2% | 50.2% | 20.5% |
| Unrestricted net assets | $117,205 | $832,028 | -$424,368 | -$116,676 | $585,748 |
| Temporarily restricted net assets | N/A | N/A | N/A | N/A | N/A |
| Permanently restricted net assets | N/A | N/A | N/A | N/A | N/A |
| Total restricted net assets | $723,951 | $1,908,417 | $1,870,836 | $743,165 | $88,363 |
| Total net assets | $841,156 | $2,740,445 | $1,446,468 | $626,489 | $674,111 |
Key data checks
| Key data checks info | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
President and CEO
Hampus Hillerstrom
Hampus Hillerstrom is President and CEO of LuMind IDSC Foundation since September 2017, after serving on the board of directors for three years. Previously, he cofounded Proclara Biosciences in 2007, a company developing a novel approach for treating Alzheimers, Parkinsons and other protein misfolding diseases.
Previously, he spent three years as an associate at leading European biotech venture capital firm HealthCap where he participated in a large number of investment transactions including several IPOs. Hampus also spearheaded a project at AstraZeneca to evaluate decisionmaking leading to Phase III clinical trials.
Hampus holds a Masters in Economics and Finance from the University of St. Gallen (Switzerland), an MBA from Harvard Business School, and an MSc in Health Sciences and Technology from MIT/Harvard Medical School (HST). Hampus and his wife, Lianor are raising sons Oskar, the oldest who has Down Syndrome, and his partner in mischief Sebastian.
Chief Scientific Officer
Richard Fisher
As the Chief Scientific Officer, Dr. Fisher directs scientific initiatives for LuMind IDSC.
Recently, Dr. Fisher was the Chief Scientific Officer at Vigil Neuroscience, where he helped build the microglia-focused biology team.
Previously, Dr. Fisher served in a senior scientific leadership role for Flagship Pioneering FL60 (now Vesalius Therapeutics); where he worked with the founders in building a stem cell-based biology team.
Dr. Fisher served as the Chief Scientific Officer at Proclara Bioscience, where he helped establish the scientific team. He was a key member in the development of a novel approach, called GAIM, to lower amyloid loads in Alzheimers disease, culminating in the clinical trials of two novel drug candidates.
Education: Post-doctoral fellowship: University of Chicago (Biophysics)
PhD: University of Iowa College of Medicine (Microbiology/Molecular Genetics)
BA: University of Iowa (Zoology)
Number of employees
Source: IRS Form 990
LuMind IDSC Foundation
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
LuMind IDSC Foundation
Highest paid employeesSOURCE: IRS Form 990
Compensation data
LuMind IDSC Foundation
Board of directorsas of 5/19/2025
Board of directors data
Anthony Providenti
Beverly Paperiello
Chris Senna DIRECTOR
Claudia Moreira
Das Narayandas
Giri Krishnamoorthy
Hector Guinness
Jeff Strobel
Karen Gaffney
Lasandra Brill DIRECTOR
Ludevine Van Der Heyden
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? yes
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
The organization's leader identifies as:
The organization's co-leader identifies as: